Why COAs Matter in Peptide Research

A Certificate of Analysis (COA) is one of the most important documents a researcher can evaluate before working with any peptide compound. It provides third-party or in-house verified data confirming the identity, purity, and quality of the peptide in a given batch. Without a COA, there is no independent verification that the compound you’re working with is what the label claims — a critical gap in any rigorous research context.

If you’re new to peptide documentation, start with our foundational piece: What Is a COA?. This article goes deeper — into how to actually interpret what a COA shows, section by section.

For an overview of our quality and purity standards, visit our Quality and Purity page.

HPLC Results Section

High-Performance Liquid Chromatography (HPLC) is the gold standard method for measuring peptide purity. The HPLC section of a COA will typically show a chromatogram — a graph plotting detector response against time — along with a calculated purity percentage.

What to look for:

• Purity percentage: Research-grade peptides typically show 98%+ purity. Values below 95% may indicate synthesis issues or inadequate purification. Values below 90% are generally considered unsuitable for serious research applications.
• Peak shape: The main peak on the chromatogram should be sharp and well-separated from smaller impurity peaks. Broad, irregular, or overlapping peaks suggest lower purity or co-eluting impurities.
• Retention time: While not always directly interpretable without matching reference standards, the retention time value should be present and consistent with expected compound behavior.
• Number of peaks: Fewer secondary peaks generally indicate better purity. Multiple large secondary peaks are a red flag.

A COA reporting 98.6% HPLC purity means that, in the analytical sample tested, 98.6% of the detected signal corresponds to the target compound. The remaining 1.4% consists of synthesis by-products, truncated sequences, or other impurities.

Mass Spectrometry Data

Mass spectrometry (MS) confirms molecular identity — not just purity. While HPLC tells you how much of something is present, MS tells you what it is. A complete COA should include both.

What to look for:

• Observed molecular weight (MW): The MS result should show a measured mass that matches the theoretical molecular weight of the target peptide. This is typically expressed in Daltons (Da) or as a mass-to-charge ratio (m/z).
• Expected vs. observed: The COA should clearly state both the expected MW and the observed MW. These should match closely — typically within 0.5–1 Da or within the instrument’s stated tolerance.
• Charge states: Larger peptides often appear as multiply charged ions in electrospray ionization (ESI-MS). The COA may show [M+H]+, [M+2H]2+, or similar notations. This is normal and expected for longer sequences.
• Fragmentation data (MS/MS): Some higher-quality COAs include tandem mass spec data. This is a more rigorous identity confirmation and indicates a higher level of analytical diligence.

If the observed MW differs significantly from the expected value, the compound is not what it claims to be — full stop.

Compound Identification Section

This section of the COA identifies the specific compound being analyzed. It should include:

• Compound name: The full chemical or research name of the peptide (e.g., the full IUPAC name or recognized research designation).
• Amino acid sequence: For peptide compounds, a sequence notation (using one-letter or three-letter amino acid codes) is a strong indicator of analytical depth. This confirms not just mass but structural composition.
• CAS number (if applicable): Some peptides have registered CAS numbers. These should match known databases.
• Molecular formula: Should be consistent with the theoretical formula for the stated compound.

A vague compound name like “research peptide” or an absent sequence listing on a COA should raise questions. Specificity here matters.

Batch Traceability

Every legitimate COA should tie results to a specific production batch. This enables traceability — the ability to connect a specific vial to a specific test result.

What to look for:

• Lot/batch number: Should be clearly printed on both the COA and the vial label. These must match.
• Test date: When was the analysis performed? Recent testing (within a reasonable manufacturing window) is preferred. A COA dated years before the purchase date may indicate reused documentation.
• Quantity tested: Some COAs specify the sample size or lot size. This helps contextualize whether testing was performed on a representative sample.
• Expiry or retest date: Some suppliers include a recommended retest window, particularly important for long-term storage research planning.

Batch traceability is a basic requirement for GMP-style documentation practices, even in non-pharmaceutical research contexts. Its absence is a significant red flag.

Testing Lab Credentials

Who performed the analysis matters as much as the result itself. Third-party testing by an independent, credentialed laboratory provides a meaningfully higher level of assurance than in-house testing.

What to evaluate:

• Lab name and contact information: Should be clearly stated. A real lab should be verifiable — you can search for them, check their website, confirm their services.
• Third-party vs. in-house: Third-party labs have no financial incentive to report favorable results. In-house labs may be competent, but there is an inherent conflict of interest. Prefer third-party where available.
• Accreditation: ISO/IEC 17025 accreditation is the recognized standard for analytical testing laboratories. Its presence on a COA signals a lab operating under external quality oversight.
• Instrument disclosure: Quality COAs often specify the instrument used (e.g., “Shimadzu HPLC” or “Waters Acquity”). This level of transparency is a positive signal.

For more detail on how TrueCanPeptides approaches testing, see our article on how we test our peptides.

Red Flags to Watch For

Knowing what a good COA looks like also means recognizing when something is missing or suspicious:

• No mass spectrometry data: HPLC alone confirms purity, not identity. A COA without MS data cannot confirm you have the right compound.
• Vague purity ranges: “>95%” without a specific value is less useful than “97.8%.” Ranges may obscure poor results.
• No lab name or anonymous testing: Untraceable testing is not testing in any meaningful research sense.
• Lot number mismatch: If the vial lot number doesn’t match the COA lot number, the documentation doesn’t apply to your specific batch.
• No date: Undated COAs cannot be evaluated for relevance or freshness.
• Suspiciously round numbers: A purity of exactly “100%” or “99%” with no decimal is unusual for real analytical instrumentation and may warrant scrutiny.
• PDF-only with no lab contact: A COA that cannot be traced to a real testing entity is effectively unverifiable.

For research purposes only. Not intended for human use. This content is educational and does not constitute medical advice.